Hangzhou Tigermed Consulting (300347.SZ) has repurchased a total of 8.7739 million shares, spending 444 million yuan.

Hangzhou Tigermed Consulting (300347.SZ) announced that as of February 10, 2025, the company's share repurchase special securities account has repurchased a total of 8.7739 million shares of the company through centralized auction trading, accounting for 1.0144% of the total share capital of the company and 1.1827% of the total A-share capital of the company. The highest transaction price was 55.30 yuan/share and the lowest transaction price was 48.17 yuan/share, with a total transaction amount of 4.44 billion yuan (excluding transaction costs).